The pioneering brain-computer interface company, Neuralink, has announced a breakthrough with the development of its Blindsight implant, designed to restore vision for individuals who have lost both eyes.
The company’s founder, Elon Musk, revealed the innovation on Wednesday, saying that the device has received “breakthrough device” designation from the US Food and Drug Administration (FDA) earlier this week.
“Much appreciated, US FDA!” Musk shared on X, formerly known as Twitter. He emphasized that the implant “will enable even those who have lost both eyes and their optic nerve to see.” This revolutionary technology could even benefit individuals blind since birth, provided their visual cortex is still functional.
Musk explained that while initial vision quality will be low-resolution, comparable to early video game graphics, the technology is expected to evolve rapidly. Future advancements could enhance visual quality to surpass natural sight, potentially enabling users to see beyond the visible spectrum, including infrared and ultraviolet light, or even radar wavelengths.
Linda Yaccarino, CEO of X, praised the innovation, calling it “miracles for many unfolding” in a post on the platform.
Although the Blindsight implant has not yet to begin human trials, and neither Neuralink nor the FDA has set a specific timeline, the potential applications are generating significant excitement.
In parallel, Neuralink is testing another implant designed to enable quadriplegic individuals to control digital devices using their thoughts alone. The chip processes neural signals and transmits them to external devices, such as computers or smartphones, empowering patients with spinal cord injuries to interact with the digital world.
Founded in 2016 by Elon Musk and a team of experts in neuroscience, biochemistry, and robotics, Neuralink has previously developed brain-chip technology aimed at restoring body control for those suffering from paralysis. With FDA approval, two individuals have already received successful brain-chip implants.
Main Image: Teslarati
